Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Mendelian randomization to inform a clinical trial of chitotriosidase inhibition for pulmonary sarcoidosis

Submitted by Anna Hakala on Mon, 10/06/2025 - 14:27
  • Read more about Mendelian randomization to inform a clinical trial of chitotriosidase inhibition for pulmonary sarcoidosis

Genetic predisposition to high BMI and changes in BMI during adolescence modulate associations between adult BMI and plasma molecules involved in glucose metabolism

Submitted by Anna Hakala on Mon, 10/06/2025 - 14:25
  • Read more about Genetic predisposition to high BMI and changes in BMI during adolescence modulate associations between adult BMI and plasma molecules involved in glucose metabolism

Multi-ancestry genome-wide and transcriptome-wide association analyses identified new risk loci and genes for inflammatory bowel disease

Submitted by Anna Hakala on Mon, 10/06/2025 - 14:16
  • Read more about Multi-ancestry genome-wide and transcriptome-wide association analyses identified new risk loci and genes for inflammatory bowel disease

A Multi-Polygenic Risk Score Approach Incorporating Physical Activity Genotypes for Predicting Type 2 Diabetes and Associated Comorbidities: A FinnGen Study

Submitted by Anna Hakala on Mon, 10/06/2025 - 14:15
  • Read more about A Multi-Polygenic Risk Score Approach Incorporating Physical Activity Genotypes for Predicting Type 2 Diabetes and Associated Comorbidities: A FinnGen Study

A Mendelian Randomization Study on the Causal Relationship between Blood Lipids and Lung Cancer

Submitted by Anna Hakala on Mon, 10/06/2025 - 14:12
  • Read more about A Mendelian Randomization Study on the Causal Relationship between Blood Lipids and Lung Cancer

Evidence for causal effects of serum trace minerals on risk of gastric diseases: A mendelian randomization study

Submitted by Anna Hakala on Mon, 10/06/2025 - 14:08
  • Read more about Evidence for causal effects of serum trace minerals on risk of gastric diseases: A mendelian randomization study

Genetically predicted causal associations between 152 blood-related exposures and pan-cancer in the framework of prediction, prevention and personalized medicine: a study integrating Mendelian randomization and bioinformatics

Submitted by Anna Hakala on Mon, 10/06/2025 - 14:06
  • Read more about Genetically predicted causal associations between 152 blood-related exposures and pan-cancer in the framework of prediction, prevention and personalized medicine: a study integrating Mendelian randomization and bioinformatics

Multi-Omics Mendelian Randomization Identifies Therapeutic Targets for Sjögren’s Disease with Clinical and Bayesian Validation

Submitted by Anna Hakala on Mon, 10/06/2025 - 14:05
  • Read more about Multi-Omics Mendelian Randomization Identifies Therapeutic Targets for Sjögren’s Disease with Clinical and Bayesian Validation

Mendelian Randomization of Serum Micronutrients in relation to Lower Back Pain and Sciatica protection: focus on Vitamin A

Submitted by Anna Hakala on Mon, 10/06/2025 - 14:03
  • Read more about Mendelian Randomization of Serum Micronutrients in relation to Lower Back Pain and Sciatica protection: focus on Vitamin A

Exploring the Potential Causal Relationship between Protein Ratio and Atopic Dermatitis Using a Two-Sample Mendelian Randomization Approach

Submitted by Anna Hakala on Mon, 10/06/2025 - 11:22
  • Read more about Exploring the Potential Causal Relationship between Protein Ratio and Atopic Dermatitis Using a Two-Sample Mendelian Randomization Approach

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 98
  • Page 99
  • Page 100
  • Page 101
  • Current page 102
  • Page 103
  • Page 104
  • Page 105
  • Page 106
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social
Follow us on LinkedIn
https://www.linkedin.com/company/finngen/

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement